Guided Therapeutics, Inc.
GTHP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $20 | $20 | $7 | $9 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $22 | $22 | $9 | $10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | 67.5% | – | -200% |
| EBITDA | -$1 | -$1 | -$0 | -$0 |
| % Margin | – | -535.9% | – | -49,400% |
| Net Income | -$1 | -$1 | -$0 | -$1 |
| % Margin | – | -693.2% | – | -65,200% |
| EPS Diluted | -0.01 | -0.011 | -0.007 | -0.012 |
| % Growth | 8.3% | -60.3% | 44.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |